Entry |
|
Name |
Arbaclofen placarbil (USAN/INN) |
Formula |
C19H26ClNO6
|
Exact mass |
399.1449
|
Mol weight |
399.86
|
Structure |
|
Class |
Neuropsychiatric agent
DG01565 GABA-B receptor agonist
|
Remark |
|
Efficacy |
Antispasmodic, GABA-B receptor agonist |
Comment |
Active form of prodrug: Arbaclofen (R-Baclofen) [DR: D09791]
Treatment of gastro-esophageal reflux disease (GERD) and spasticity
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01565 GABA-B receptor agonist
DG01354 Arbaclofen
D08861 Arbaclofen placarbil
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Metabotropic glutamate receptor family
GABA (metabotropic)
GABBR
D08861 Arbaclofen placarbil (USAN/INN)
Prodrugs [br08324.html]
D08861
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01565 GABA-B receptor agonist
DG01354 Arbaclofen
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 27
1 C8y C 21.4200 -20.1600
2 C1c C 21.4200 -18.7600
3 C8x C 20.2300 -20.8600
4 C8x C 22.6100 -20.8600
5 C1b C 20.2300 -18.0600
6 C1b C 22.6100 -18.0600
7 C8x C 20.2300 -22.2600
8 C8x C 22.6100 -22.2600
9 C6a C 19.0400 -18.7600
10 N1b N 23.8700 -18.7600
11 C8y C 21.4200 -22.9600
12 O6a O 17.7800 -18.0600
13 O6a O 19.0400 -20.1600
14 X Cl 21.4200 -24.3600
15 C7a C 25.0600 -18.0600
16 O7a O 26.3200 -18.6900
17 O6a O 25.0600 -16.6600
18 C1c C 27.5100 -17.9900
19 O7a O 28.7700 -18.6200
20 C1c C 27.5100 -16.5900
21 C1a C 26.2500 -15.8900
22 C1a C 28.7000 -15.8900
23 C7a C 29.9600 -17.9200
24 C1c C 31.2200 -18.6200
25 O6a O 29.9600 -16.5200
26 C1a C 32.4100 -17.8500
27 C1a C 31.2200 -20.0200
BOND 27
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 1
5 2 6 1 #Up
6 3 7 2
7 4 8 1
8 5 9 1
9 6 10 1
10 7 11 1
11 9 12 1
12 9 13 2
13 11 14 1
14 8 11 2
15 10 15 1
16 15 16 1
17 15 17 2
18 16 18 1
19 18 19 1
20 18 20 1 #Up
21 20 21 1
22 20 22 1
23 19 23 1
24 23 24 1
25 23 25 2
26 24 26 1
27 24 27 1
|